Llorens Josep 4
4 · HAEMONETICS CORP · Filed May 17, 2023
Insider Transaction Report
Form 4
Llorens Josep
SVP, Global Manufacturing
Transactions
- Tax Payment
Common Stock
2023-05-16$89.21/sh−319$28,458→ 19,886 total - Award
Common Stock
2023-05-15+3,084→ 20,205 total - Award
Non-qualified Stock Option (Right to Buy)
2023-05-15+6,968→ 6,968 totalExercise: $89.16Exp: 2030-05-15→ Common Stock (6,968 underlying)
Footnotes (5)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
- [F4]Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I.
- [F5]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.